Retinal degenerations that cause the loss of our sharpest (central) vision are often associated with excessive accumulation of lipofuscin within the retinal pigment epithelium (RPE). In ABCA4 (ABCR)-associated retinopathies, recent experimental studies have outlined specific pathogenetic steps causing this toxic accumulation; and therapies have been proposed to slow down the accumulation and delay the progression to blindness. The goal of the current program of research is to define precisely the micro- and macro-topography of lipofuscin accumulation and the rate of progression of this abnormality in patients with ABCA4 disease. This will lay the groundwork for targeted therapeutics designed to affect the natural history of this earliest detectable ABCA4 disease feature.
The first aim i s to quantify accumulation and clearance stages of lipofuscin longitudinally in patients with ABCA4 mutations; the hypothesis will be tested that visual dysfunction is first detectable during the clearance stage while the accumulation stage is subclinical.
The second aim i s to design and validate a simple outcome measure based on lipofuscin microtopography to be used in clinical trials designed to modify the natural history of ABCA4 disease sequence.
The third aim i s to perform pilot studies with two compounds that show potential for modifying the natural history of central or midperipheral ABCA4 disease. The questions posed in these aims can only be answered in human subjects using state-of-the-art quantitative ophthalmic techniques. The planned investigations are broadly relevant to many other hereditary maculopathies as well as to age-related macular degeneration (AMD) which partially shares with ABCA4 disease the pathophysiology of lipofuscin accumulation. The long-term goal of the research program is to unravel the pathophysiologic mechanisms in human hereditary retinal degenerations, contribute to the design of mechanism-specific therapies, and develop means to test their effectiveness. ? ?

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY013203-05
Application #
6865166
Study Section
Biology and Diseases of the Posterior Eye Study Section (BDPE)
Program Officer
Dudley, Peter A
Project Start
2000-08-05
Project End
2008-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
5
Fiscal Year
2005
Total Cost
$237,750
Indirect Cost
Name
University of Pennsylvania
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Beltran, William A; Cideciyan, Artur V; Boye, Shannon E et al. (2017) Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations. Mol Ther 25:1866-1880
Strauss, Rupert W; Ho, Alex; Muñoz, Beatriz et al. (2016) The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1. Ophthalmology 123:817-28
Matsui, Rodrigo; McGuigan Iii, David B; Gruzensky, Michaela L et al. (2016) SPATA7: Evolving phenotype from cone-rod dystrophy to retinitis pigmentosa. Ophthalmic Genet 37:333-8
Cideciyan, Artur V; Swider, Malgorzata; Jacobson, Samuel G (2015) Autofluorescence imaging with near-infrared excitation:normalization by reflectance to reduce signal from choroidal fluorophores. Invest Ophthalmol Vis Sci 56:3393-406
Zhang, Ning; Tsybovsky, Yaroslav; Kolesnikov, Alexander V et al. (2015) Protein misfolding and the pathogenesis of ABCA4-associated retinal degenerations. Hum Mol Genet 24:3220-37
Matsui, Rodrigo; Cideciyan, Artur V; Schwartz, Sharon B et al. (2015) Molecular Heterogeneity Within the Clinical Diagnosis of Pericentral Retinal Degeneration. Invest Ophthalmol Vis Sci 56:6007-18
Beltran, William A; Cideciyan, Artur V; Iwabe, Simone et al. (2015) Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease. Proc Natl Acad Sci U S A 112:E5844-53
Cideciyan, Artur V; Swider, Malgorzata; Schwartz, Sharon B et al. (2015) Predicting Progression of ABCA4-Associated Retinal Degenerations Based on Longitudinal Measurements of the Leading Disease Front. Invest Ophthalmol Vis Sci 56:5946-55
Beltran, William A; Cideciyan, Artur V; Guziewicz, Karina E et al. (2014) Canine retina has a primate fovea-like bouquet of cone photoreceptors which is affected by inherited macular degenerations. PLoS One 9:e90390
Huang, Wei Chieh; Cideciyan, Artur V; Roman, Alejandro J et al. (2014) Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations. Invest Ophthalmol Vis Sci 55:1810-22

Showing the most recent 10 out of 41 publications